Boston Scientific, founded in 1979, develops minimally invasive medical technologies across cardiovascular, rhythm management, neurology, endoscopy, urology and pelvic health, serving 127 countries.
Boston Scientific is a global medical technology company founded in 1979 that develops minimally invasive medical technologies and solutions across multiple medical specialties to improve patient outcomes. The company employs more than 53,000 people worldwide, treats over 44 million patients annually and serves 127 countries. It invests approximately $1.68 billion a year in research and development.
Its work spans several technical domains: minimally invasive medical technology, cardiovascular interventions, rhythm management, neurology, endoscopy, urology, pelvic health and medical device R&D. Product lines include minimally invasive technologies for cardiovascular interventions, solutions addressing heart rhythm management and neurological conditions, endoscopic medical technologies, and technologies for urology and pelvic health conditions.
The company describes its culture as mission-driven, under the phrase "advancing science for life". Its stated values include caring deeply about patients and each other, pursuing meaningful innovation, maintaining high performance standards, collaborating globally across teams, embracing diversity as a strength and bringing a winning spirit to complex healthcare challenges. Work is organised around close collaboration with healthcare professionals to understand their needs, with a patient-centred focus on more time, quality of life and moments with loved ones.
